Human T-cell leukemia virus type 2 post-transcriptional control protein p28 is required for viral infectivity and persistence in vivo
© Yamamoto et al; licensee BioMed Central Ltd. 2008
Received: 01 April 2008
Accepted: 12 May 2008
Published: 12 May 2008
Human T-cell leukemia virus (HTLV) type 1 and type 2 are related but distinct pathogenic complex retroviruses. HTLV-1 is associated with adult T-cell leukemia and a variety of immune-mediated disorders including the chronic neurological disease termed HTLV-1-associated myelopathy/tropical spastic paraparesis. In contrast, HTLV-2 displays distinct biological differences and is much less pathogenic, with only a few reported cases of leukemia and neurological disease associated with infection. In addition to the structural and enzymatic proteins, HTLV encodes regulatory (Tax and Rex) and accessory proteins. Tax and Rex positively regulate virus production and are critical for efficient viral replication and pathogenesis. Using an over-expression system approach, we recently reported that the accessory gene product of the HTLV-1 and HTLV-2 open reading frame (ORF) II (p30 and p28, respectively) acts as a negative regulator of both Tax and Rex by binding to and retaining their mRNA in the nucleus, leading to reduced protein expression and virion production. Further characterization revealed that p28 was distinct from p30 in that it was devoid of major transcriptional modulating activity, suggesting potentially divergent functions that may be responsible for the distinct pathobiologies of HTLV-1 and HTLV-2.
In this study, we investigated the functional significance of p28 in HTLV-2 infection, proliferation, and immortaliztion of primary T-cells in culture, and viral survival in an infectious rabbit animal model. An HTLV-2 p28 knockout virus (HTLV-2Δp28) was generated and evaluated. Infectivity and immortalization capacity of HTLV-2Δp28 in vitro was indistinguishable from wild type HTLV-2. In contrast, we showed that viral replication was severely attenuated in rabbits inoculated with HTLV-2Δp28 and the mutant virus failed to establish persistent infection.
We provide direct evidence that p28 is dispensable for viral replication and cellular immortalization of primary T-lymphocytes in cell culture. However, our data indicate that p28 function is critical for viral survival in vivo. Our results are consistent with the hypothesis that p28 repression of Tax and Rex-mediated viral gene expression may facilitate survival of these cells by down-modulating overall viral gene expression.
The human T-cell leukemia viruses (HTLV types 1–4) are classified as complex retroviruses and members of the genus Deltaretrovirus . HTLV-1 and HTLV-2 infections are the most prevalent worldwide, whereas infections with HTLV-3 and HTLV-4 were discovered only recently in a very limited number of individuals in Africa [2, 3]. Although people infected with HTLV have a persistent antiviral immune response, these patients fail to clear virally infected cells. A small percentage of HTLV-1-infected individuals develop adult T-cell leukemia (ATL), a CD4+ lymphocyte malignancy, and various lymphocyte-mediated inflammatory diseases such as HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) [4–7]. However, only a few cases of atypical hairy cell leukemia or neurologic disease have been associated with HTLV-2 infection [8–12]. HTLV-1 and HTLV-2 have the capacity to promote T-lymphocyte growth both in cell culture and in infected individuals; however, the mechanism by which the virus persists in the infected individual, ultimately resulting in the oncogenic transformation of T-lymphocytes, is not completely understood.
In addition to the gag, pol, and env genes that encode the structural and enzymatic proteins, HTLV encodes tax/rex and accessory genes from pX open reading frames (ORFs) located in the 3' region of the genome. Tax increases the rate of transcription from the viral long terminal repeat (LTR) [13–15] and modulates the transcription or activity of numerous cellular genes involved in cell growth and differentiation, cell cycle control, and DNA repair [16–20]. Compelling evidence indicates that the pleiotropic effects of Tax on cellular processes are required for the transforming or oncogenic capacity of HTLV [21–23]. Rex acts post-transcriptionally by preferentially binding, stabilizing and selectively exporting the unspliced and incompletely spliced viral mRNAs from the nucleus to the cytoplasm, thus controlling the expression of the structural and enzymatic proteins as well as virion production [24–26]. Although both Tax and Rex are key positive regulators essential for efficient viral replication and, ultimately, cellular transformation, it has been hypothesized that the unregulated expression of these genes would result in the death of the infected cell in vivo via the induction of apoptosis and/or host immune response.
Growing evidence indicates that the HTLV-1 p30 and the HTLV-2 p28 accessory proteins encoded by pX ORF II regulate HTLV gene expression and therefore may contribute to the pathobiology of the virus. The homology between p30 and p28 is limited with the N-terminal 49 amino acids of p28 sharing 77% identity with the C-terminal portion of p30 [27, 28]. Using over-expression studies, we and others reported that the nuclear/nucleolar-localizing p30 or p28 (p30/p28) specifically bind to and retain tax/rex mRNA in the nucleus [29, 30]. Furthermore, inhibition of tax/rex mRNA export by p30/p28 appears to be co-transcriptional and requires an interaction between p30/p28 and Tax complexes on the viral promoter, which facilitates the co-migration of p30/p28 with RNA pol II until the protein encounters the newly synthesized downstream RNA binding sequence . In addition, Sinha-Datta et al. demonstrated that p30 and Rex form a ribonucleoprotein ternary complex specifically on the tax/rex mRNA, which is consistent with its selective nuclear retention . Interestingly, p30 also has been shown to interact with transcriptional co-activators/acetyltransferases, p300/CBP and TIP60, displaying both positive and inhibitory transcriptional effects on viral and cellular promoters [33–37]. Unlike p30, p28 does not display any significant transcriptional regulatory activity [29–31] suggesting the possibility of distinct or additional functions. Together, these findings suggest that p30/p28 facilitates virus and/or infected cell survival by regulating viral gene expression.
Under standard cell culture conditions, p30 was dispensable for viral infection, replication and immortalization of T-lymphocytes in vitro . In vivo studies using a rabbit model of infection have revealed that p30 is important for the establishment of persistent infection [39, 40]. However, more recent identification of HTLV-1 Hbz, found on the opposite coding strand partially overlapping p30, makes precise interpretation of these studies difficult. HTLV-2 containing a large deletion of the 3' proximal pX region maintained the capacity to efficiently replicate in and transform primary T-lymphocytes in culture, but was significantly attenuated in inoculated rabbits [41, 42]. However, the specific contribution of the HTLV-2 accessory gene products, particularly p28, to overall virus biology has not been determined.
In this study, we evaluated the functional role of p28 in the context of an HTLV-2 infectious molecular clone and determined its contribution to viral replication and viral-induced immortalization in cell culture as well as viral replication kinetics and persistence in inoculated rabbits. Our findings indicate that the loss of p28 and thus its documented repressive post-transcriptional regulatory effect on Tax/Rex was not sufficient to disrupt the capacity of the virus to immortalize primary T-lymphocytes in culture. However, in the in vivo rabbit infection model, a p28-defective HTLV-2 had reduced replication and ability to establish persistent infection. These results suggest that the posttranscriptional repression of retroviral gene expression by p28 down-modulates viral replication thereby directly affecting cell signaling and survival. In addition, p28 may facilitate immune escape by HTLV infected cells by preventing their recognition by the host immune response.
Generation and characterization of the HTLV-2 p28 knockout mutant
HTLV-2Δp28 promoted virus-induced proliferation and immortalization of PBMCs
In vivorabbit inoculation results
Detection of HTLV-2 sequences in PBMCs from inoculated rabbitsa
Weeks Post Inoculation
Inoculum and Rabbit
The importance of the HTLV-2 nonstructural or accessory proteins in virus biology either in cell culture or in inoculated animals has not been investigated thoroughly. A previous study evaluated an HTLV-2 molecular clone containing a large deletion within the proximal pX region, which at the time was thought to delete the coding sequences for all the known accessory proteins. Results from this study indicated that this region, which later was shown to contain open reading frames (ORFs) for p10 and p11 , was dispensable for viral infection and cellular transformation in vitro . Subsequently, it was demonstrated that this deletion resulted in reduced proviral load and maintenance of infection in vivo . However, the role of the HTLV-2 p28 accessory protein encoded by ORF II located in exon 3 of tax/rex was not addressed directly in these studies. We previously demonstrated that exogenously over-expressed p28 functions as a negative regulator of viral replication by binding to and retaining tax/rex mRNA in the nucleus, thus repressing Tax and Rex protein production and overall viral gene expression [30, 31]. In this study, a site directed mutation was introduced in an infectious clone of HTLV-2 that severely truncated p28 (HTLV-2Δp28) while maintaining the ability of the virus to express other gene products. Subsequently, we examined the expression of p28 and determined its biological significance for the infectivity and immortalization of primary T-lymphocytes in cell culture and viral infectivity and persistence in vivo.
Data from our transient transfection studies revealed that, in the context of a proviral clone, the repressive effects of p28 on Tax-mediated transcription and Rex function were not apparent (Fig. 2A &2B). In fact, the loss of p28 resulted in a reproducible, but not significant decrease in Tax activity (75–90%). Consistent with the functional reporter assays, quantitative real-time RT-PCR revealed that the levels of tax/rex and gag/pol mRNA were not dramatically different in cells transfected with HTLV-2 and HTLV-2Δp28 proviral clones (Fig. 2C). Although we could detect p28 encoding mRNA (approximately 103-104 total copies per 106 copies of gapdh), p28 protein was below the limit of detection by Western blot. Due to alternative splicing, p28 has the potential to be expressed from two distinct singly-spliced mRNAs (both of these mRNAs also have the potential to produce the truncated p22/p20rex). Studies by Li and Green showed that these two mRNAs have significantly different expression levels in newly infected PBMCs (105 vs 103 copies per 106 copies of cellular gapdh) . Although nearly impossible to definitively confirm experimentally, we hypothesize that the low copy number mRNA is the primary transcript utilized to encode p28, thus resulting in low protein expression (below our limit of detection). To date, with the exception of the HTLV-1 HBZ protein, none of the HTLV-1 or HTLV-2 accessory proteins have been detected in transfected or infected cells. Interestingly, the mRNA copy number of HBZ in infected cells was 10- to 100-fold higher than the other accessory gene mRNAs, which was consistent with its detection . However, we did confirm that over-expression of p28 from a cDNA expression plasmid, but not Δp28, down-regulated Tax-mediated viral transcription in a dose-dependent manner (Fig 3A). Furthermore, we demonstrated that the repressive effects of p28 on Tax-mediated transcription and Rex activity were not detectable in stable cell lines as represented by variable p19 production less than or equal to wild-type HTLV-2 production levels (Fig 4A). Therefore, we speculate that p28 protein expression is temporally regulated and not expressed following transient proviral DNA plasmid delivery or in stable transfectants and/or a threshold level of p28 is required for the repressive activity.
Results from our short-term proliferation and immortalization assays indicated that the reported repressive effects of the HTLV-2 p28 on Tax and Rex [30, 31] were not sufficient to disrupt the capacity of the virus to infect, induce proliferation, and/or immortalize primary T lymphocytes in vitro (Fig 5A and 5B). Therefore, similar to the HTLV-1 and other HTLV-2 pX ORF-encoded accessory proteins [38, 41, 47], p28 appears to be dispensable for efficient viral infectivity, replication and primary T-lymphocyte immortalization capacity in vitro.
Based on the efficient infectivity and immortalization of cells in vitro and the transient infection observed in 729.HTLV-2Δp28-inoculated rabbits, we hypothesize that the function of p28 and its role in HTLV-2 biology involves early virus/host interactions that may include virus spread and/or survival of the infected cell. We observed reduced proviral load as early as two weeks post inoculation as compared to that in the wild type virus-infected rabbits (Table 1). By four weeks, p28 mutant inoculated rabbits showed a significant reduction in the antibody response to viral gene products, which continued for the duration of the study (Fig. 6). By week eleven, we failed to detect a visible PCR amplified band or realtime PCR proviral loads in all HTLV-2Δp28-inoculated rabbits. All wild-type HTLV-2-inoculated rabbits showed variable but significant proviral loads. To date, p28 has been documented to repress Tax-mediated transcription and Rex activity; based on our results, we speculate that p28 might function in concert with other viral gene products to tightly regulate viral replication and/or influence virus expression in the infected lymphocyte to promote infected cell survival (apoptosis vs cell proliferative signals), viral spread, and establishment of persistent infection. It remains possible that p28 may have multiple activities that function at different stages of the infection process. Future experiments designed to quantitatively assess viral infectivity of rabbits at 1–2 days post inoculation will be required to definitively rule out an early block in infection in vivo. Interestingly, the gross phenotype of HTLV-2Δp28 in vivo showed significant similarities to HTLV-1 HBZ, p30 and p13 virus mutants. More detailed comparative studies will be required to dissect mechanistic differences which may provide important insight regarding how viral proteins function causing the distinct pathobiology between HTLV-1 and HTLV-2.
In summary, our data confirmed that over-expression of p28 in cell culture repressed viral gene expression, but in the context of a replicating virus, was completely dispensable for efficient cellular immortalization. Utilizing a rabbit model of infection, these are the first biological studies to demonstrate the critical requirement of the p28 accessory protein in the establishment of HTLV-2 infection in vivo. It is likely that p28, as a negative regulator of Tax and Rex, is critical in the temporal regulation of gene expression upon infection and promotes cell survival. This importance is not seen without the selective pressure applied by the presence of a functional immune system. These biological studies have led the way for future studies that are needed to understand the function of p28. Such studies will entail identifying the functional domains of the protein involved in localization, protein interactions, and RNA binding as well as precisely identifying the viral mRNA response element. In addition, gene array studies may provide clues as to whether p28 expression by itself has any direct or indirect cellular effects that facilitate the survival of the T-lymphocyte, the natural target for HTLV infection and cellular transformation.
293T cells and 729 B cell lines were maintained in Dulbecco's modified Eagle and Iscove medium, respectively, supplemented with 10% fetal bovine serum (FBS), 2 mM glutamine, penicillin (100 U/mL), and streptomycin (100 ug/mL). Human and rabbit peripheral blood mononuclear cells (PBMCs) were isolated using Ficoll Hypaque (Amersham, Piscataway, NJ) and Percoll® (Amersham, Piscataway, NJ), respectively, and cultured in RPMI 1640 medium supplemented with 20% FBS, glutamine and antibiotics as above, plus 10 U/mL of recombinant interleukin-2 (IL-2; Roche Applied Biosciences, Indianapolis, IN).
The p28 cDNA expression vector (CMV-p28-AU1) and the wild type (wt) HTLV-2 infectious proviral clone (pH6neo) were described previously [30, 48]. Using PCR mutagenesis and CMV-p28-AU1 as a template, a single nucleotide mutation (C to A) was introduced in the p28 reading frame. This change (nt 7333 of the pH6neo proviral sequence) resulted in a stop codon in the seventh amino acid (aa) of p28, designated Δp28. This specific mutation was designed to not alter the aa sequence of either Tax or Rex, both of which share overlapping reading frames with p28. The Δp28 mutation expressed in the context of the proviral clone pH6neo, was designated HTLV-2Δp28. The mutation in all mutant plasmids was confirmed by DNA sequencing. The Tax reporter plasmid, LTR-2-Luc, and the transfection efficiency control plasmid, TK-Renilla, were described previously [30, 31].
Transfection, reporter assays, and p19 Gag ELISA
293T cells (2 × 105) were transfected using Lipofectamine® (Invitrogen, Carlsbad, CA) as recommended by the manufacturer. For p28 protein detection, cells were transfected with 1 μg of cDNA expression plasmids and 10 ng of TK-Renilla. Cell lysates were prepared at 48 h post transfection and normalized for transfection efficiency prior to Western blot analysis. To assess the repressive effects of p28 or Δp28 by Tax reporter assays, cells were transfected with 1 μg wtHTLV-2 in the presence or absence of variable concentrations (0.2–0.4 μg) of p28 or Δp28 cDNA expression vector and 0.1 μg of LTR-2-Luc, and 10 ng of TK-Renilla or 1 μg HTLV-2Δp28 and 0.1 μg of LTR-2-Luc, and 10 ng of TK-Renilla. Cell lysates were harvested at 48 h post transfection and dual luciferase activity was measured. The data represent average luciferase activity values after normalization for transfection efficiency for three independent experiments. To generate the 729HTLV-2Δp28 stable transfectant, the proviral plasmid clone containing neor gene was introduced into cells by nucleofection using the Nucleofector kit V (Amaxa Biosystems, Gaithersburg, MD). Stable transfectants containing the desired proviral clone were isolated following incubation in 24-well culture dishes in medium containing 1 mg/ml Geneticin (Gibco, Carlsbad, CA). Following a 4–5 weeks selection period, viable cells were expanded and maintained in culture for further analysis. The well-characterized wtHTLV-2 729 producer cell line (729pH6neo) used in this study was described previously [46, 49].
To detect p28, 50 μg of total cell lysates from transfected cells was separated by SDS-PAGE and transferred to a nitrocellulose membrane (Amersham, Piscataway, NJ). Rabbit polyclonal antibodies against p28 or a monoclonal antibody to AU1 (Covance Research Products, Denver, PA,) was used for p28 detection. Rabbit polyclonal antibody to β-actin (Novus Biological, Littleton, CO) was used as a loading control. Proteins were visualized using the ECL western blotting analysis system (Santa Cruz Biotechnology, Santa Cruz, CA).
DNA isolation, standard PCR, and Taqman real-time PCR
DNA was isolated from 729 producer cells and rabbit peripheral blood mononuclear cells (PBMCs) using the PURGENE DNA purification system (Gentra, Minneapolis, MN). Rabbit DNA (1 μg) was subjected to a standard 40-cycle PCR amplification for detection of integrated provirus and the product was visualized on a 2% agarose gel stained with ethidium bromide. The primer pair used in the PCR, based on the pH6neo sequence, was TRE-PH-S (5'-41GAG TCA TCG ACC CAA AAG G59-3') and TRE-PH-AS (5'-298TGC GCT TTT ATA GAC TCG GC279-3'), which amplified a 257 bp product in the HTLV-2 LTR. Taqman real-time PCR (Applied Biosystems, Foster City, CA) using 500 ng of rabbit DNA and 40 cycle amplification was performed in a 25 ul reaction to quantify the proviral copy number per cell in infected rabbit PBMCs using primers and probes directed towards Gag sequences . The reaction contained 100 ng (25 ng/μL) of each primer and the probe at a concentration of 100 pmol/μL. A standard curve was generated for each run using duplicate samples of log10 dilutions of a plasmid containing the Gag sequences. The copy number for each sample was determined from the standard curve, and the copy number per cell for each sample calculated based on the estimate that 1 μg PBMC DNA is equal to 67,300 cells.
Short-term proliferation and long-term immortalization coculture assays
Short term microtiter proliferation assays were performed as detailed previously with modifications [45, 50]. Briefly, freshly isolated human PBMCs were pre-stimulated with 2 μg/ml PHA and 10 U/ml IL-2 (Roche, Indianapolis, IN) for three days. 729 producer cells (2 × 103) were irradiated (100 Gy) and co-cultured with 104 pre-stimulated PBMCs in the presence of IL-2 in 96-well round bottom plates. Wells were enumerated for growth and split 1:3 at weekly intervals. Cell proliferation was confirmed by MTS assay using CellTiter 96® Aqueous One Solution Reagent as recommended by the manufacturer (Promega, Madison, WI). For the long-term immortalization assays, 106 irradiated producer cells were co-cultivated with 2 × 106 freshly isolated PBMCs with 10 U/ml IL-2 in 24-well culture plates . HTLV expression was confirmed by detection of p19 Gag protein in the culture supernatant measured at weekly intervals using a commercially available ELISA (Zeptometrix, Buffalo, NY). Viable cells were counted weekly by trypan blue exclusion. Cells inoculated with HTLV-2 that continued to produce p19 Gag antigen and proliferate 12 weeks post co-culture in the presence of exogenous interleukin-2 (IL-2) were identified as HTLV immortalized. For each assay, at least three independent experiments were performed using PBMCs from distinct healthy donors.
Rabbit inoculation, ex vivo culture, and serologic analysis
Twelve week-old specific pathogen-free New Zealand White rabbits (Harlan, Indianapolis, IN) were inoculated with approximately 1 × 107 gamma-irradiated (100 Gy) 729 viral producer cells (6 rabbits per group) or 729 uninfected control cells (2 rabbits) via the lateral ear vein. The virus-containing inocula were equilibrated based on HTLV-2 p19 Gag production (ELISA). At weeks 0, 1, 2, 4, 6, 8, and 11 after inoculation, 10 ml of blood was drawn from the central auricular artery from each animal and rabbit plasma and PBMCs were isolated. HTLV Western blot assay (HTLV Blot 2.4 Western Blot Assay; MP Diagnostics, Singapore) was used to examine serum reactivity to specific viral antigenic determinants. Serum showing reactivity to Gag (p24 or p19) and Env (gp21 or gp46) antigens was classified as positive for HTLV-2 seroreactivity. A commercial HTLV ELISA kit (Vironostika HTLV-I/II Microelisa System; bioMerieux, Durham, NC) was used to quantitate HTLV-2 serum antibody using plasma diluted 1:100 to obtain values within the linear range of the assay. Data is shown as absorbance values. DNA was isolated from rabbit PBMCs using the PURGENE DNA purification system (Gentra, Minneapolis, MN) and subjected to proviral load analysis by realtime PCR.
We thank Kate Hayes for editorial comments on the manuscript and Tim Vojt for figure preparations. This work was supported by a grant from the National Institutes of Health (CA100730) to PLG.
- Lairmore M, Franchini G: Human T-Cell Leukemia Virus Types 1 and 2. Fields Virology. Edited by: Fields BN, Knipe DM, Howley PM, Chanock RM, Monath TP, Melnick JL, Roizman B, Straus SE. 2007, Philadelphia, PA USA. , Lippincott Williams, and Wilkins, 5th: Chapter 56, 2071-2106.Google Scholar
- Wolfe ND, Heneine W, Carr JK, Garcia AD, Shanmugam V, Tamoufe U, Torimiro JN, Prosser AT, Lebreton M, Mpoudi-Ngole E, McCutchan FE, Birx DL, Folks TM, Burke DS, Switzer WM: Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters. Proc Natl Acad Sci U S A. 2005, 102 (22): 7994-7999. 10.1073/pnas.0501734102.PubMed CentralView ArticlePubMedGoogle Scholar
- Calattini S, Chevalier SA, Duprez R, Bassot S, Froment A, Mahieux R, Gessain A: Discovery of a new human T-cell lymphotropic virus (HTLV-3) in Central Africa. Retrovirology. 2005, 2 (1): 30-10.1186/1742-4690-2-30.PubMed CentralView ArticlePubMedGoogle Scholar
- Takatsuki K: Discovery of adult T-cell leukemia. Retrovirology. 2005, 2: 16-10.1186/1742-4690-2-16.PubMed CentralView ArticlePubMedGoogle Scholar
- Osame M, Igata A, Matsumoto M, Usuku K, Izumo S, Kosaka K: HTLV-I associated myelopathy: A report of 85 cases. Ann Neurol. 1987, 22: 116-Google Scholar
- Yoshida M: Discovery of HTLV-1, the first human retrovirus, its unique regulatory mechanisms, and insights into pathogenesis. Oncogene. 2005, 24 (39): 5931-5937. 10.1038/sj.onc.1208981.View ArticlePubMedGoogle Scholar
- Gallo RC: History of the discoveries of the first human retroviruses: HTLV-1 and HTLV-2. Oncogene. 2005, 24 (39): 5926-5930. 10.1038/sj.onc.1208980.View ArticlePubMedGoogle Scholar
- Rosenblatt JD, Giorgi JV, Golde DW, Ezra JB, Wu A, Winberg CD, Glaspy J, Wachsman W, Chen IS: Integrated human T-cell leukemia virus II genome in CD8 + T cells from a patient with "atypica" hairy cell leukemia: evidence for distinct T and B cell lymphoproliferative disorders. Blood. 1988, 71: 363-369.PubMedGoogle Scholar
- Berger JR, Svenningsson A, Raffanti S, Resnick L: Tropical spastic paraparesis-like illness occurring in a patient dually infected with HIV-1 and HTLV-II. Neurology. 1991, 41: 5-7.View ArticleGoogle Scholar
- Hjelle B, Appenzeller O, Mills R, Alexander S, Torrez-Martinez N, Jahnke R, Ross G: Chronic neurodegenerative disease associated with HTLV-II infection. Lancet. 1992, 339: 645-646. 10.1016/0140-6736(92)90797-7.View ArticlePubMedGoogle Scholar
- Harrington Jr WJ, Sheremata W, Hjelle B, Dube DK, Bradshaw P, Foung SK, Snodgrass S, Toedter G, Cabra L, Poiesz B: Spastic ataxia associated with human T-cell lymphotropic virus type II infection. Annals Neurol. 1993, 7: 1031-1034.Google Scholar
- Poiesz B, Dube D, Dube S, Love J, Papsidero L, Uner A, Hutchinson R: HTLV-II-associated cutaneous T-cell lymphoma in a patient with HIV-1 infection. N Engl J Med. 2000, 342 (13): 930-936. 10.1056/NEJM200003303421304.View ArticlePubMedGoogle Scholar
- Cann AJ, Rosenblatt JD, Wachsman W, Shah NP, Chen ISY: Identification of the gene responsible for human T-cell leukemia virus transcriptional regulation. Nature. 1985, 318: 571-574. 10.1038/318571a0.View ArticlePubMedGoogle Scholar
- Felber BK, Paskalis H, Kleinman-Ewing C, Wong-Staal F, Pavlakis GN: The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats. Science. 1985, 229: 675-679. 10.1126/science.2992082.View ArticlePubMedGoogle Scholar
- Inoue JI, Yoshida M, Seiki M: Transcriptional (p40x) and post-transcriptional (p27xIII) regulators are required for the expression and replication of human T-cell leukemia virus type I genes. Proc Natl Acad Sci USA. 1987, 84: 3653-3657. 10.1073/pnas.84.11.3653.PubMed CentralView ArticlePubMedGoogle Scholar
- Leung K, Nabel GJ: HTLV-I transactivator induces interleukin-2 receptor expression through an NFkB-like factor. Nature. 1988, 333: 776-778. 10.1038/333776a0.View ArticlePubMedGoogle Scholar
- Mulloy JC, Kislyakova T, Cereseto A, Casareto L, LoMonico A, Fullen J, Lorenzi MV, Cara A, Nicot C, Giam C, Franchini G: Human T-cell lymphotropic/leukemia virus type 1 Tax abrogates p53- induced cell cycle arrest and apoptosis through its CREB/ATF functional domain. J Virol. 1998, 72 (11): 8852-8860.PubMed CentralPubMedGoogle Scholar
- Ressler S, Morris GF, Marriott SJ: Human T-cell leukemia virus type 1 Tax transactivates the human proliferating cell nuclear antigen promoter. J Virol. 1997, 71: 1181-1190.PubMed CentralPubMedGoogle Scholar
- Schmitt I, Rosin O, Rohwer P, Gossen M, Grassmann R: Stimulation of cyclin-dependent kinase activity and G1- to S-phase transition in human lymphocytes by the human T-cell leukemia/lymphotropic virus type 1 Tax protein. J Virol. 1998, 72 (1): 633-640.PubMed CentralPubMedGoogle Scholar
- Siekevitz M, Feinberg MB, Holbrook N, Wong-Staal F, Greene WC: Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the trans-activator (tat) gene product of human T-cell leukemia virus, type I. Proc Natl Acad Sci USA. 1987, 84: 5389-5393. 10.1073/pnas.84.15.5389.PubMed CentralView ArticlePubMedGoogle Scholar
- Robek MD, Ratner L: Immortalization of CD4+ and CD8+ T-lymphocytes by human T-cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone. J Virol. 1999, 73: 4856-4865.PubMed CentralPubMedGoogle Scholar
- Ross TM, Narayan M, Fang ZY, Minella AC, Green PL: Tax transactivation of both NFkB and CREB/ATF is essential for Human T-cell leukemia virus type 2-mediated transformation of primary human T-cells. J Virol. 2000, 74: 2655-2662. 10.1128/JVI.74.6.2655-2662.2000.PubMed CentralView ArticlePubMedGoogle Scholar
- Wycuff DR, Marriott SJ: The HTLV-1 Tax Oncoprotein:Hypertasking at the molecular level. Front Biosci. 2005, 10: 620-642. 10.2741/1558.View ArticlePubMedGoogle Scholar
- Ballaun C, Farrington GR, Dobrovnik M, Rusche J, Hauber J, Bohnlein E: Functional analysis of human T-cell leukemia virus type I Rex-response element: Direct RNA binding of Rex protein correlates with in vivo binding activity. J Virol. 1991, 65: 4408-4413.PubMed CentralPubMedGoogle Scholar
- Kusuhara K, Anderson M, Pettiford SM, Green PL: Human T-cell leukemia virus type 2 Rex protein increases stability and promotes nuclear to cytoplasmic transport of gag/pol and env RNAs. J Virol. 1999, 73: 8112-8119.PubMed CentralPubMedGoogle Scholar
- Narayan M, Kusuhara K, Green PL: Phosphorylation of two serine residues regulates human T-cell leukemia virus type 2 Rex function. J Virol. 2001, 75 (18): 8440-8448. 10.1128/JVI.75.18.8440-8448.2001.PubMed CentralView ArticlePubMedGoogle Scholar
- Koralnik IJ, Gessain A, Klotman ME, Lo Monico A, Berneman ZN, Franchini G: Protein isoforms encoded by the pX region of human T-cell leukemia/lymphotropic virus type I. Proc Natl Acad Sci U S A. 1992, 89 (18): 8813-8817. 10.1073/pnas.89.18.8813.PubMed CentralView ArticlePubMedGoogle Scholar
- Ciminale V, D'Agostino DM, Zotti L, Franchini G, Felber BK, Chieco-Bianchi L: Expression and characterization of proteins produced by mRNAs spliced into the X region of the human T-cell leukemia/lymphotropic virus type II. Virology. 1995, 209 (2): 445-456. 10.1006/viro.1995.1277.View ArticlePubMedGoogle Scholar
- Nicot C, Dundr JM, Johnson JR, Fullen JR, Alonzo N, Fukumoto R, Princler GL, Derse D, Misteli T, Franchini G: HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication. Nat Med. 2004, 10 (2): 197-201. 10.1038/nm984.View ArticlePubMedGoogle Scholar
- Younis I, Khair L, Dundr M, Lairmore MD, Franchini G, Green PL: Repression of human T-cell leukemia virus type 1 and 2 replication by a viral mRNA-encoded posttranscriptional regulator. J Virol. 2004, 78: 11077-11083. 10.1128/JVI.78.20.11077-11083.2004.PubMed CentralView ArticlePubMedGoogle Scholar
- Younis I, Boris-Lawrie K, Green PL: Human T-cell leukemia virus ORF II p28 encodes a post-transcriptional repressor that is recruited at the level of transcription. J Virol. 2006, 80: 181-191. 10.1128/JVI.80.1.181-191.2006.PubMed CentralView ArticlePubMedGoogle Scholar
- Sinha-Datta U, Datta A, Ghorbel S, Dodon MD, Nicot C: Human T-cell Lymphotrophic Virus Type I Rex and p30 Interactions Govern the Switch between Virus Latency and Replication. J Biol Chem. 2007, 282 (19): 14608-14615. 10.1074/jbc.M611219200.View ArticlePubMedGoogle Scholar
- Zhang W, Nisbet JW, Albrecht B, Ding W, Kashanchi F, Bartoe JT, Lairmore MD: Human T-lymphotropic virus type 1 p30II regulates gene transcription by binding CREB binding protein/p300. J Virol. 2001, 75 (20): 9885-9895. 10.1128/JVI.75.20.9885-9895.2001.PubMed CentralView ArticlePubMedGoogle Scholar
- Zhang W, Nisbet JW, Bartoe JT, Ding W, Lairmore MD: Human T-lymphotropic virus type 1 p30II functions as a transcription factor and differentially modulates CREB-responsive promoters. J Virol. 2000, 74 (23): 11270-11277. 10.1128/JVI.74.23.11270-11277.2000.PubMed CentralView ArticlePubMedGoogle Scholar
- Michael B, Nair AM, Datta A, Hiraragi H, Ratner L, Lairmore MD: Histone acetyltransferase (HAT) activity of p300 modulates human T lymphotropic virus type 1 p30II-mediated repression of LTR transcriptional activity. Virology. 2006, 354 (2): 225-239. 10.1016/j.virol.2006.07.002.PubMed CentralView ArticlePubMedGoogle Scholar
- Awasthi S, Sharma A, Wong K, Zhang J, Matlock EF, Rogers L, Motloch P, Takemoto S, Taguchi H, Cole MD, Luscher B, Dittrich O, Tagami H, Nakatani Y, McGee M, Girard AM, Gaughan L, Robson CN, Monnat RJ, Harrod R: A Human T-Cell Lymphotropic Virus Type 1 Enhancer of Myc Transforming Potential Stabilizes Myc-TIP60 Transcriptional Interactions. Mol Cell Biol. 2005, 25 (14): 6178-6198. 10.1128/MCB.25.14.6178-6198.2005.PubMed CentralView ArticlePubMedGoogle Scholar
- Harrod R, Kuo YL, Tang Y, Yao Y, Vassilev A, Nakatani Y, Giam CZ: p300 and p300/cAMP-responsive element-binding protein associated factor interact with human T-cell lymphotropic virus type-1 Tax in a multi-histone acetyltransferase/activator-enhancer complex. J Biol Chem. 2000, 275 (16): 11852-11857. 10.1074/jbc.275.16.11852.View ArticlePubMedGoogle Scholar
- Derse D, Mikovits J, Ruscetti F: X-I and X-II open reading frames of HTLV-I are not required for virus replication or for immortalization of primary T-cells in vitro. Virology. 1997, 237: 123-128. 10.1006/viro.1997.8781.View ArticlePubMedGoogle Scholar
- Bartoe JT, Albrecht B, Collins ND, Robek MD, Ratner L, Green PL, Lairmore MD: Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo. J Virol. 2000, 74 (3): 1094-1100. 10.1128/JVI.74.3.1094-1100.2000.PubMed CentralView ArticlePubMedGoogle Scholar
- Silverman LR, Phipps AJ, Montgomery A, Ratner L, Lairmore MD: Human T-cell lymphotropic virus type 1 open reading frame II-encoded p30II is required for in vivo replication: evidence of in vivo reversion. J Virol. 2004, 78: 3837-3845. 10.1128/JVI.78.8.3837-3845.2004.PubMed CentralView ArticlePubMedGoogle Scholar
- Green PL, Ross TM, Chen ISY, Pettiford S: Human T-cell leukemia virus type II nucleotide sequences between env and the last exon of tax/rex are not required for viral replication or cellular transformation. J Virol. 1995, 69: 387-394.PubMed CentralPubMedGoogle Scholar
- Cockerell GL, Rovank J, Green PL, Chen ISY: A deletion in the proximal untranslated pX region of human T-cell leukemia virus type II decreases viral replication but not infectivity in vivo. Blood. 1996, 87 (3): 1030-1035.PubMedGoogle Scholar
- Li M, Green PL: Detection and quantitation of HTLV-1 and HTLV-2 mRNA species by real-time RT-PCR. J Virol Methods. 2007, 142 (1-2): 159-168. 10.1016/j.jviromet.2007.01.023.PubMed CentralView ArticlePubMedGoogle Scholar
- Arnold J, Yamamoto B, Li M, Phipps AJ, Younis I, Lairmore MD, Green PL: Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1. Blood. 2006, 107 (10): 3976-3982. 10.1182/blood-2005-11-4551.PubMed CentralView ArticlePubMedGoogle Scholar
- Xie L, Yamamoto B, Haoudi A, Semmes OJ, Green PL: PDZ binding motif of HTLV-1 Tax promotes virus-mediated T-cell proliferation in vitro and persistence in vivo. Blood. 2006, 107 (5): 1980-1988. 10.1182/blood-2005-03-1333.PubMed CentralView ArticlePubMedGoogle Scholar
- Xie L, Green PL: Envelope is a major viral determinant of the distinct in vitro cellular transformation tropism of human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2. J Virol. 2005, 79 (23): 14536-14545. 10.1128/JVI.79.23.14536-14545.2005.PubMed CentralView ArticlePubMedGoogle Scholar
- Robek M, Wong F, Ratner L: Human T-cell leukemia virus type 1 pX-I and pX-II open reading frames are dispensable for the immortalization of primary lymphocytes. J Virol. 1998, 72: 4458-4462.PubMed CentralPubMedGoogle Scholar
- Chen ISY, McLaughlin J, Gasson JC, Clark SC, Golde DW: Molecular characterization of genome of a novel human T-cell leukaemia virus. Nature. 1983, 305: 502-505. 10.1038/305502a0.View ArticlePubMedGoogle Scholar
- Green PL, Xie Y, Chen ISY: The internal methionine codons of the human T-cell leukemia virus type-II rex gene are not required for p24Rex production or virus replication and transformation. J Virol. 1990, 64: 4914-4921.PubMed CentralPubMedGoogle Scholar
- Persaud D, Munoz JL, Tarsis SL, Parks ES, Parks WP: Time course and cytokine dependence of human T-cell lymphotropic virus type 1 T-lymphocyte transformation as revealed by a microtiter infectivity assay. J Virol. 1995, 69: 6297-6303.PubMed CentralPubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.